EP4014976
Aprósítentan til notkunar við meðhöndlun á háþrýstingi og tengdum sjúkdómum í samsetningu með valsartan
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
26.2.2018EP published:
4.9.2024EP application number:
21202979.7
EP translation filed:
21.10.2024Grant published:
15.11.2024EPO information:
European Patent Register
Max expiry date:
25.2.2038Expiry date:
25.2.2027Next due date:
28.2.2027
Title in English:
APROCITENTAN FOR USE IN THE TREATMENT OF HYPERTENSION AND RELATED DISEASES IN COMBINATION WITH VALSARTANLanguage of the patent:
English
Timeline
Today
26.2.2018EP application
4.9.2024EP Publication
21.10.2024Translation submitted
15.11.2024Registration published
25.2.2027Expires
Owner
Name:
Idorsia Pharmaceuticals LtdAddress:
Hegenheimermattweg 91, 4123 Allschwil, CH
Inventor
Name:
BOLLI, MartinAddress:
4123 Allschwil, CH
Name:
BELLET, MarcAddress:
4123 Allschwil, CH
Name:
CLOZEL, MartineAddress:
4123 Allschwil, CH
Name:
IGLARZ, MarcAddress:
4123 Allschwil, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
PCT/EP2017/054489Date:
27.2.2017Country:
WO
Number:
PCT/EP2017/061487Date:
12.5.2017Country:
WO
Classification
Categories:
A61K 31/506, A61K 31/401, A61K 38/05, A61K 31/41, A61P 9/12, A61K 45/06, A61K 31/4035
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 11.2.2025
Expires: 25.2.2026
Payer: G.H. Sigurgeirsson ehf.
Number: 9
Paid: 16.2.2026
Expires: 25.2.2027
Payer: G.H. Sigurgeirsson ehf.